Atlas Trials

Cathepsin Activatable Fluorescent Probe

Clinical trial NCT01626066 · COMPLETED

Trial details

NCT number
NCT01626066
Sponsor
David Kirsch
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SarcomaSoft Tissue SarcomaBreast Cancer
Start date
2012-06-01
Primary completion
2014-08-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.